Product Information
RISEDRONATE SODIUM 150 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $13.8886 per EA under NDC 65862087003. Its NADAC has been published 490 times since Feb 8, 2017.
Strength
150 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862087003
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RISEDRONATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206768On Market Since
10/21/2016
Pharmacological Classes
Price Statistics
The NADAC for RISEDRONATE SODIUM 150 MG TAB has been published 490 times since Feb 8, 2017, and over the history we have for it it has declined 84.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.8886 per EA |
|---|---|
| All-time high | $91.4002 (Feb 15, 2017) |
| All-time low | $9.8142 (May 22, 2024) |
| 52-week high | $18.0296 |
| 52-week low | $13.8886 |
| Median price | $31.5050 |
| Average price | $30.9490 |
| Largest weekly change | +58.0% (Aug 21, 2024) |
| Weeks tracked | 490 |
| Tracking since | Feb 8, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RISEDRONATE SODIUM 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for RISEDRONATE SODIUM 150 MG TAB, manufactured by Aurobindo Pharma Limited, is $13.8886 per EA (NDC 65862087003), effective Jun 24, 2026.
How has the price of RISEDRONATE SODIUM 150 MG TAB changed over time?
Over the history we have for it, the NADAC for RISEDRONATE SODIUM 150 MG TAB has declined 84.8%. It has been tracked across 490 weekly CMS publications since Feb 8, 2017.
What are the highest and lowest recorded NADAC prices for RISEDRONATE SODIUM 150 MG TAB?
Since Feb 8, 2017, the NADAC for RISEDRONATE SODIUM 150 MG TAB has ranged from a low of $9.8142 (May 22, 2024) to a high of $91.4002 (Feb 15, 2017), with a median of $31.5050 per EA.
Are there cheaper alternatives to RISEDRONATE SODIUM 150 MG TAB?
2 NADAC-published products share the same active ingredient, strength, and dosage form as RISEDRONATE SODIUM 150 MG TAB, but none are currently priced below it.
Who manufactures RISEDRONATE SODIUM 150 MG TAB?
RISEDRONATE SODIUM 150 MG TAB (NDC 65862087003) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification